Compounds > nafronyl

nafronyl and Peripheral Vascular Diseases

nafronyl has been researched along with Peripheral Vascular Diseases in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (27.27)18.2507
2000's3 (27.27)29.6817
2010's5 (45.45)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chas, J; Ciapponi, A; Cytryn, D; Franco, JV; Saenz, V; Vietto, V1
Roset, PN1
Harnan, S; Meng, Y; Michaels, J; Simpson, E; Squires, H; Stansby, G; Stevens, JW; Thomas, S2
Dobesh, PP; Persson, EL; Stacy, ZA1
Bradbury, A; Fowkes, G; Smith, FB1
Davies, L; Drummond, M1
Chalmers, TC; Dormandy, JA; Loosemore, TM1
Claeys, N; Cosyns, JP; Cuvelier, C; de Strihou, CV; Goffin, E; Pirson, Y; Squifflet, JP1
Bradbury, AW; Fowkes, FG; Smith, FB1
Khodabandehlou, T; Le Dévéhat, C; Mosnier, M1

Reviews

6 review(s) available for nafronyl and Peripheral Vascular Diseases

ArticleYear
Prostanoids for critical limb ischaemia.
    The Cochrane database of systematic reviews, 2018, 01-10, Volume: 1

    Topics: Alprostadil; Amputation, Surgical; Epoprostenol; Humans; Iloprost; Ischemia; Leg; Leg Ulcer; Nafronyl; Nicotinic Acids; Pentoxifylline; Peripheral Vascular Diseases; Prostaglandins; Randomized Controlled Trials as Topic; Vasodilator Agents

2018
Pharmacologic therapy for intermittent claudication.
    Pharmacotherapy, 2009, Volume: 29, Issue:5

    Topics: Cilostazol; Clinical Trials as Topic; Dietary Supplements; Drugs, Investigational; Exercise Therapy; Guidelines as Topic; Humans; Intermittent Claudication; Meta-Analysis as Topic; Nafronyl; Pentoxifylline; Peripheral Vascular Diseases; Pyrrolidines; Risk Factors; Tetrazoles; Treatment Outcome

2009
Intravenous naftidrofuryl for critical limb ischaemia.
    The Cochrane database of systematic reviews, 2012, Jul-11, Issue:7

    Topics: Amputation, Surgical; Extremities; Female; Humans; Infusions, Intravenous; Ischemia; Male; Nafronyl; Pain; Pain Measurement; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Vasodilator Agents

2012
Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
    The British journal of surgery, 2012, Volume: 99, Issue:12

    Topics: Cilostazol; Humans; Intermittent Claudication; Nafronyl; Pain; Pentoxifylline; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Vasodilator Agents; Walking

2012
A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease.
    International angiology : a journal of the International Union of Angiology, 1994, Volume: 13, Issue:2

    Topics: Alprostadil; Amputation, Surgical; Ancrod; Arterial Occlusive Diseases; Epoprostenol; Humans; Iloprost; Nafronyl; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Survival Analysis

1994
Intravenous naftidrofuryl for critical limb ischaemia.
    The Cochrane database of systematic reviews, 2000, Issue:2

    Topics: Extremities; Humans; Infusions, Intravenous; Ischemia; Nafronyl; Peripheral Vascular Diseases; Serotonin Antagonists; Vasodilator Agents

2000

Other Studies

5 other study(ies) available for nafronyl and Peripheral Vascular Diseases

ArticleYear
Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
    The British journal of surgery, 2013, Volume: 100, Issue:13

    Topics: Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; Peripheral Vascular Diseases; Tetrazoles; Vasodilator Agents

2013
Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
    The British journal of surgery, 2013, Volume: 100, Issue:13

    Topics: Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; Peripheral Vascular Diseases; Tetrazoles; Vasodilator Agents

2013
Economic evaluation of drugs in peripheral vascular disease and stroke.
    Journal of cardiovascular pharmacology, 1994, Volume: 23 Suppl 3

    Topics: Cerebrovascular Disorders; Cost-Benefit Analysis; Decision Trees; Economics, Pharmaceutical; Health Care Costs; Humans; Ischemia; Leg; Nafronyl; Peripheral Vascular Diseases

1994
Acute renal failure due to naftidrofuryl oxalate Praxilène overdose in a kidney transplant recipient.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:9

    Topics: Acute Kidney Injury; Adult; Calcium Oxalate; Crystallization; Drug Overdose; Female; Humans; Infusions, Intravenous; Kidney Transplantation; Nafronyl; Peripheral Vascular Diseases; Vasodilator Agents

1995
Effect of naftidrofuryl on platelet aggregation in plasma from aspirin treated patients: an in vitro study.
    Clinical hemorheology and microcirculation, 2000, Volume: 22, Issue:3

    Topics: Aged; Aged, 80 and over; Aspirin; Diabetic Angiopathies; Drug Interactions; Female; Humans; Male; Middle Aged; Nafronyl; Peripheral Vascular Diseases; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasodilator Agents

2000